Skip to content

EUROAPI vs SEQENS

EUROAPI logo

EUROAPI

Active Solutions for Health

1483 employees · est. 2021 · Paris, France

VS
SEQENS logo

SEQENS

Our science for your future

1291 employees · est. 2003 · Ecully, France

SEQENS is the older company (2021 vs 2003).

Side-by-Side Comparison

EUROAPI SEQENS
Founded
2021 2003 older
Headquarters
Paris, France Ecully, France
Employees
1483 1291
Industry
Health Care, Manufacturing Biotechnology, Pharmaceutical
Funding Stage
Post-IPO Debt Private Equity
Total Funding
$755.00M Not tracked yet
Funding Rounds
1 2
Services
API Solutions, CDMO Services, Industrial Network Support Manufacture of pharmaceutical ingredients, Development of custom specialties and chemical products, Research and development across multiple scientific disciplines, Support for personal care market with specialized ingredients, Innovation-driven solutions for health and specialty sectors
Target Customers
Pharmaceutical Companies, Biotech Firms, Healthcare Providers, Animal Health Companies Pharmaceutical Companies, Personal Care Brands, Healthcare Sector, Biotechnology Firms, Specialty Chemical Companies
Taxonomy
Active Pharmaceutical IngredientsContract Development And Manufacturing OrganizationAPI ManufacturingInnovative MoleculesPharmaceutical StandardsSmall Molecules +9 Pharmaceutical SolutionsSpecialty IngredientsActive IngredientsPharmaceutical IntermediatesPharmaceutical SynthesisR&D Centers +9
Website
euroapi.com seqens.com
EUROAPI logo

About EUROAPI

EUROAPI, founded in 2021, is a leading player in the Health Care and Manufacturing industries, specializing in the production of active pharmaceutical ingredients (APIs). With a broad portfolio of approximately 200 products, the company operates under the slogan "Active Solutions for Health." Their...

SEQENS logo

About SEQENS

SEQENS positions itself as a global leader in pharmaceutical solutions and specialty ingredients, reflected in its slogan, "Our science for your future." Founded in 2003 and based in France, the company operates 16 manufacturing plants and 9 R&D centers across Europe, North America, and Asia. With a...

Also comparing in this category

Comparing more than these two?

Get EUROAPI, SEQENS and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does EUROAPI compare?

A PDF of EUROAPI and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

EUROAPI was founded in 2021, based in Paris, France, with 1,483 employees. EUROAPI, founded in 2021, is a leading player in the Health Care and Manufacturing industries, specializing in the production of active pharmaceutical ingredients (APIs). With a broad portfolio of app. SEQENS was founded in 2003, based in Ecully, France, with 1,291 employees. SEQENS positions itself as a global leader in pharmaceutical solutions and specialty ingredients, reflected in its slogan, "Our science for your future." Founded in 2003 and based in France, the compa.
EUROAPI has raised $755.00M and SEQENS no disclosed funding. Latest stage: EUROAPI Post-IPO Debt, SEQENS Private Equity.

Compare EUROAPI with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at EUROAPI on 17 Mar 2026, and SEQENS on 23 Nov 2025. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout